Hosted on MSN
Lung Cancer rising in young adults - causes, symptoms, prevention and how non smokers can stay safe
Lung cancer has till recently, been associated by older adults who are chronic smokers, but recent statistics indicate a concerning increase in young adult cases among non-smokers. The increasing ...
The study, published today in Cancer Cell, generated spatial transcriptomic maps in precancerous and more advanced stages of lung cancer to provide a deeper understanding of early lung cancer ...
News-Medical.Net on MSN
Why lung cancer in never smokers is rising and how targeted detection could reduce deaths
By Priyanjana Pramanik, MSc. Researchers reveal why lung cancer in people who never smoked is increasing and explore how ...
Spatial maps of lung precancer and cancer cells at different points in development advance understanding of the earliest stages of lung cancer Findings highlight inflammation as a driver of lung tumor ...
Most people associate lung cancer primarily with smoking, but growing evidence suggests diet plays a more significant role than previously thought. While numerous foods help protect against cancer, ...
Stenoparib is being evaluated in combination with temozolomide clinical benefit in relapsed Small Cell Lung CancerTrial is fully funded by ...
As is often the case with cancer treatments, many patients are able to benefit from therapy for a time. Tumor activity ...
9don MSN
The 'zombie cell' effect: New study explains chemotherapy resistance in lung and ovarian cancers
Researchers have identified a biological mechanism that helps explain why some lung and ovarian cancers become resistant to ...
SurvivorNet on MSN
Could timing give your cancer treatment a boost? New study on the best time to receive immunotherapy & chemo for non-small cell lung cancer
A new randomized clinical trial showed that receiving immunochemotherapy infusions earlier in the day may help patients with NSCLC live longer.
Froedtert surgeons used an FDA‑approved "glowing" drug to find a tiny lung tumor and spare healthy lung tissue.
The FDA has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneous, chemo-free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results